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Colorectal cancer (CRC) is one of the commonest cancers in
Western countries, with 5000 annual cases (over 10% of all
cancers) in Sweden (IARC, 1990; Centre for Epidemiology, 1999).
Over 90% of CRCs are adenocarcinomas but malignant carcinoids
are relatively common at young age (Hemminki and Li, 2001).
Most CRCs are sporadic and migrant studies have shown that
environmental factors are important (Potter, 1999). At least 10%
of the CRC burden has been suggested to be genetic (Lynch and de
la Chapelle, 1999) and familial risks in population-based studies
have varied between 1.7 and 2.0 (Fuchs et al, 1994; Carstensen
et al, 1996; Hemminki et al, 1998; Hemminki and Vaittinen,
1999). According to a recent twin study, 60% of the variation in
CRC was assigned to random environmental effects and 35% to
heritable factors; shared environmental effects accounted for 5%
which was not significant (Lichtenstein et al, 2000). The most
common hereditary CRC disorder is hereditary nonpolyposis CRC
(HNPCC), due to defective DNA mismatch repair (Wheeler et al,
2000). The estimates of the proportion HNPCC among all CRC
have varied widely, depending on the criteria used and the popula-
tion studied (Potter, 1999; Wheeler et al, 2000). In Finland, muta-
tion-positive cases account for 3% of all CRC (Aaltonen et al,
1998; Salovaara et al, 2000). Because the relative risk of CRC is
high in mutation carriers (cumulative incidence of CRC up to age
70 is 82%) compared to the general population (cumulative inci-
dence 1.6), HNPCC may alone be responsible for a familial risk of
1.5 in Finland, i.e.: 0.82 ´ 0.03/0.016 = 1.54 (Aarnio et al, 1999).
HNPCC is characterized by a dominant inheritance, relatively
early onset (before age 50 years), proximal location of tumours
(70% proximal to splenic flexture, compared to 30% in sporadic
tumours), high penetrance and presentation of multiple CRCs and
other cancers, particularly at the endometrium, small intestine,
urinary tract, stomach and biliary system (Lynch and Smyrk, 1996;
Aarnio et al, 1999; Lynch and de la Chapelle, 1999; Wheeler et al,
2000). Another hereditary cancer syndrome, familial adenomatous
polyposis (FAP), is due to the mutations in the APC gene and
accounts for less than 1% of all CRC (Vogelstein and Kinzler,
1998). Due to prophylactic colectomies and removal of precan-
cerous lesions, the proportion of HNPCC and FAP is presumed to
be decreasing among all CRC. 
Familial clustering of CRC is thought to occur even when the
cases are not part of a defined cancer syndrome (Fuchs et al, 1994;
Hemminki et al, 2001; Dong and Hemminki, 2001). To investigate
this, we analysed the risk of colorectal adenocarcinoma by family
history using the nationwide Swedish Family-Cancer Database
(Hemminki et al, 1998, 2001; Hemminki and Vaittinen, 1999). The
database offers unique possibilities for reliable estimation of
familial risks, because the data on family relationships and cancers
were obtained from registered sources of practically complete
coverage. We used the anatomic location of CRC, diagnostic age
and other cancers in the family as clues to estimate the proportion
of HNPCC among all familial cancers. We define familial cancer
strictly as parental cancer so as to be compatible with the dominant
mode of HNPCC inheritance. This study is the largest follow-up
study of familial CRC and the only one solely on adenocarcinoma. 
SUBJECTS AND METHODS 
The Swedish Family-Cancer Database includes all persons born in
Sweden after 1934 with their biological parents, totalling over 9.6
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retrieved from the nationwide Swedish Cancer Registry from
years 1958 to 1996. The completeness of colon and rectal cancer
registration in the 1970s has been estimated to be 96.4% and
98.0%, respectively, and is now considered to be close to 100%.
The percentage of cytologically or histologically verified cases by
site, sex and age at diagnosis for colon and rectal cancers has been
98–99% (Centre for Epidemiology, 1999). The Family-Cancer
Database has a gap among those born between 1935 and 1940 who
died between 1960 and 1996. Many of these individuals lack links
to parents in the Database and this probably causes a deficit of
some cancers and a somewhat inflated risk estimates for fatal
cancers. A 4-digit diagnostic code according to the 7th revision of
the International Classification of Diseases (ICD-7) was used. The
following ICD-7 codes were pooled: ‘oral’ cancer comprised codes
161 (larynx) and 140–148 (lip, mouth, pharynx), except for code
142 (salivary glands); ‘lymphoma’, comprised codes 200 (non-
Hodgkin’s lymphoma), 201 (Hodgkin’s disease) and 202 (reticu-
losis); and ‘leukaemia’ comprised codes 204–207 (leukaemias), 208
(polycystaemia vera) and 209 (myelofibrosis). ICD codes 153.0 to
154.9, excluding 1541 for anus, were used for CRC. Based on the
ICD codes, the anatomical location of CRC was classified as
‘proximal’ including right-sided sections, and ‘distal’ including
left-sided sections of the colon and rectum; the splenic flexure was
the dividing line of the proximal and distal locations. The histolo-
gical classification of colorectal cancer was used to define adeno-
carcinoma, the only type of CRC considered in this study. 
Family history information was collected on all first-degree rel-
atives (parents, siblings, and children) but only the parent–offspring
relationship was used in the present study, to cover only a dom-
inant mode of inheritance. Moreover, families were counted only
once even if more than one offspring or parent was affected. In
case of more than one affected sibling, the first affected was
selected. If both parents were affected, the father was selected. The
Amsterdam criteria were considered among our classification of
HNPCC (Vasen et al, 1991). Follow-up was started at birth or
January 1958, whichever came latest. Follow-up was terminated
on death, emigration, or the closing data of the study, December
31, 1996. Standardized incidence ratios (SIRs) were calculated as
the ratio of observed (O) to expected (E) number of cases. The
expected numbers were calculated from 5-year age-, period-, sex-
specific incidence rates (Esteve et al, 1994). Confidence intervals
(95%CI) were calculated assuming a Poisson distribution (Esteve
et al, 1994). 
The population attributable proportion of cases with a family
history of CRC was estimated as follows: (familial SIR-1)/familial
SIR  ´ proportion of familial cases (Rothman and Greenland,
1998). 
RESULTS 
The Family-Cancer Database included 3722 offspring and 63 698
parents with colorectal adenocarcinoma (Table 1). Proximal sites
accounted for 29% and distal sites 61% of both parental and
offspring cases, leaving some 10% of cases where location was
‘other’, including unspecified parts. The ratio of proximal to distal
cases was 33:67 for offspring and parents. Familial cases
accounted for 9.82% of offspring CRC. 
The number of familial pairs is shown in Table 2 by anatomic
site. Familial risks in offspring CRC were calculated for proximal
and distal cancers. The number of proximal offspring–parent pairs
was 36; mixed pairs numbered 124; distal pairs numbered 137. The
distribution fits the binomial (34% + 66%)2, suggesting that the
offspring location of the tumour is independent of the parental loca-
tion. When both offspring and parents presented with proximal
CRC, the SIR was 2.32. Any other combination of sites resulted in
SIRs of 1.87–2.00. The population attributable proportion of family
history can be estimated from the familial SIR of 2.00 for all CRC,
and the familial proportion of 9.82% giving 4.91%. 
Familial risks in offspring were calculated by age at diagnosis
(Table 3). Because of different age distributions in the offspring
and parents, the age groups were divided at 40 and 50 years,
respectively. In the youngest age group of proximal cancers, the
SIR was 25.72, compared to the oldest group of proximal cancers
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Table 1 Number of colorectal adenocarcinoma cases by anatomic site and family history 
Colorectal adenocarcinoma Parents Offspring 
subsites
All cases All cases Familial cases Familial % 
Proximal 18604 (29.21%, 32.14%a) 1076 (29.12%, 32.36%a) 106 9.79 
Distal 39281 (61.67%, 67.86%a) 2249 (60.87%, 67.64%a) 224 9.96 
Others 5813 (9.12%) 370 (10.01%) 33 8.92 
All colorectum 63698 (100.00%) 3695 (100.00%) 363 9.82 
a% of the sum of proximal + distal cancers. 
Table 2 SIR for colorectal adenocarcinoma subsites in offspring by parental colorectal adenocarcinoma 
Parents’s colorectal
Offspring’s colorectal adenocarcinoma subsites 
adenocarcinoma Proximal Distal All colorectum 
subsites
O E SIR 95%CI O E SIR 95%CI O E SIR 95%CI 
Proximal 36 15.55 2.32 1.62 3.13 63 33.73 1.87 1.43 2.36 110 54.90 2.00 1.65 2.40 
Distal 61 31.66 1.93 1.47 2.44 137 68.43 2.00 1.68 2.35 217 111.51 1.95 1.70 2.21 
All colorectum 106 51.52 2.06 1.68 2.47 224 111.46 2.01 1.76 2.28 363 181.58 2.00 1.80 2.21of 2.19. In the youngest age groups of proximal-distal and distal-
proximal cancers the SIRs were 16.33 and 14.94, respectively. In
the youngest age group of distal-distal cancers the SIR was 6.77.
The oldest age groups in each pair of subsites showed uniform
SIRs: proximal-proximal (2.19), proximal-distal (1.65), distal-
proximal (1.88) and distal-distal (1.97). The diagnostic age of the
offspring influenced the risks only when parents were diagnosed
before age 50 years. 
Offspring CRC risks were assessed by parental cancers in Table 4.
Offspring were analysed separately when diagnosed <40 years of
age. Offspring proximal CRC was increased when parents had
gastric (borderline significance), small intestinal, endometrial,
prostate and bone cancer, in addition to parental CRC. Most of
these SIRs were higher when offspring were diagnosed before age
40; however, increases for small intestinal and prostate cancers
were not significant and by bone cancer no cases were recoded.
For distal CRC, with almost twice the number of cases compared
to proximal sites, only parental CRC and endometrial cancers
caused a significant increase. Early onset offspring CRC was
increased by parental nervous system cancer. 
Only 12 families of a total of 3.0 million families in the
Database (0.0004%) fulfilled the Amsterdam criteria of 3 affected
individuals. All 3 comprised 1 parent and 2 offspring. Of these 36,
18 (51%) were proximal and 17 (49%) were distal; the location of
one could not be identified. 
DISCUSSION 
The present overall familial risk of 2.00 for colorectal adenocarci-
noma broadly agrees with the estimates from other population-
based studies, taking into account our age limit of 61 years and the
fact that the previous studies did not focus on a specific histology
(Fuchs et al, 1994; Carstensen et al, 1996). The population attri-
butable proportion for family history of 4.91% in the present study
was also consistent with the 7% estimate from a US study on first-
degree relatives because the inclusion of all first-degree relatives
gives an exaggerated attributable proportion (Fuchs et al, 1994). 
We characterized familial CRC in different ways, some of
which are novel. The SIR for proximal CRC (2.32) was higher
than that for distal CRC (2.00), particularly in younger individuals,
(offspring <40 and parents <50) age groups (25.72 vs. 6.77). On
the other hand, in the older age groups, anatomic site had no effect
and SIRs remained below 2.0. The ratio among familial cases of
proximal to distal sites was 34:66. The sum of the mixed sites
(offspring proximal-parental distal + offspring distal-parental
proximal) was exactly as predicted by a binomial distribution
(0.34 + 0.66)2. The anatomic location of familial CRC in offspring
appeared thus to be largely independent of the CRC location in
parents. The extracolonic sites which associated with CRC were
endometrium, stomach, small intestine, prostate, bone and nervous
system. However, only endometrial cancer associated with both
proximal and distal CRC. The association with prostate cancer was
of borderline significance. 
HNPCC is the most common of the dominant hereditary CRC
syndromes and its proportion among all CRC is an important ques-
tion for cancer prevention and the search for novel susceptibility
genes (Wheeler et al, 2000). The definition of HNPCC is based on
the occurrence of CRC in family members, or more recently, on
the demonstration of mutations in the mismatch repair genes. The
widely used Amsterdam criteria require that CRC occurs in at least
Colorectal cancer 971
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 3 close relatives in 2 or more generations (Boland, 1998). These
criteria cannot be applied to our database because only 2 genera-
tions are available for studies on adult cancers. Thus only 12
HNPCC families were identified among a total of 3 million fami-
lies. In other studies, applying the Amsterdam criteria, the propor-
tion of HNPCC among all CRC has ranged from below 1 to 15%
(Evans et al, 1997; Potter, 1999; Peel et al, 2000). In Finland, with
2 common founder mutations, the proportion of mutation-positive
HNPCC cases is 3% (Salovaara et al, 2000). Such proportions
depend on the study population, its age-structure and the
frequency of founder mutations. More recently, mutation
screening and prophylactic measures among families and diag-
nosed gene carriers may affect the population estimates. These
factors appear to have caused a decrease in the frequency of FAP
in the Swedish population. The diagnosis, defined as multiple
synchronous CRCs, has disappeared from the Cancer Registry
and, unless in situ cancers are considered, it is not possible to
confirm any aggregation due to FAP. The Amsterdam criteria
require that FAP be excluded. We assume that very little of our
reported familial aggregation was due to FAP. 
In contrast to FAP, several findings in the present study
confirmed that we could identify HNPCC. High risks were
observed at proximal sites and in the younger age groups, and at
the extracolonic sites, including endometrium, stomach and small
intestine cancers. HNPCC is assumed to affect proximal and distal
colorectum in the ratio of 70:30, opposite to localization of
sporadic tumours, 30:70 (Lynch and Smyrk, 1996; Lynch and de la
Chapelle, 1999). If this were true, we could obtain a fairly accurate
estimate on the proportion of HNPCC among all familial cases.
Then the odds of finding an HNPCC tumour in a proximal
compared to a distal site should be 5.4 (i.e, 70/30: 30/70).
Similarly, according to a binomial distribution: (0.70 + 0.30)2 =
49% proximal-proximal sites, 42% proximal-distal or distal-
proximal sites, and 9% distal-distal sites. Thus, 50% of the effects
of HNPCC should be found at proximal sites, shared by offspring
and parents for which the SIR was 2.32; conversely only 10% of
the effect should be at distal sites, shared by offspring and parents,
for which the SIR was 2.00. Such a small difference in observed
SIR can at most accommodate a 20% aetiological proportion for
HNPCC among all familial CRC. However, recent limited evidence,
including data from the families fulfilling the Amsterdam criteria
and mutation analysis, suggests that the 70:30 proximal-distal
distribution of HNPCC may be too high and a 50:50 distribution
may be more likely (Aaltonen et al, 1998; Peel et al, 2000;
Salovaara et al, 2000). 
Endometrial cancer in the CRC families provides an independ-
ent means of estimating the proportion of familial CRC due to
HNPCC, based on the assumption that the increase in endometrial
cancer in CRC families were only due to HNPCC and that the risk
of endometrial cancer could be somewhat higher in HNPCC than
that of CRC (Aarnio et al, 1999; Hemminki et al, 1999; Lynch and
de la Chapelle, 1999; Wheeler et al, 2000). The SIR for offspring
proximal CRC was equally high as the SIR for endometrial cancer,
SIR 2.32; for distal CRC the increase (SIR 2.00, excess in SIR
1.00) was 2 times higher than that at endometrium (1.54, excess in
SIR 0.54). Thus most proximal and close to 50% of distal CRC
could be due to HNPCC. Because distal CRC is more than twice as
common as proximal CRC, the above reasoning would suggest
that some 50% of familial CRC were due to HNPCC. However,
the association of gastric and small intestinal cancer with CRC
was limited entirely to the proximal colon. 
The above analyses were based on relatively small numbers,
leaving substantial margins of error. Furthermore the data were
based on indirect standardization (the SIR). Formally, SIRs from 2
populations are comparable only if the expected values were
derived from the same population. As this was not strictly the case,
small inaccuracies were probably introduced. The alternative
approach of using direct standardization is tenuous with sparse
data (Hemminki and Vaittinen, 1999). 
These data are consistent with the notion that HNPCC is an
important, probably predominant cause of CRC in the small group
of young patients with proximal neoplasms but it has hardly any
effect in the large group of older distal patients. Our 0–61-year-old
population showed an overall familial risk of colorectal adenocar-
cinoma of 2.00 to offspring of parents with the same tumour. In
9.82% of families with an affected offspring, a parent was also
affected, giving a population attributable proportion of 4.91. This
can be compared to the Finnish estimate of mutation-positive
HNPCC cases of 3% among all CRC. The incidence of CRC is
lower in Finland than in Sweden, while Finnish HNPCC families
are characterized by 2 common founder mutations that are rare in
Sweden (Aaltonen et al, 1998; Salovaara et al, 2000), probably
invalidating a direct comparison. Our best estimates for familial
CRC due to HNPCC ranged from 20 to 50%. The overall propor-
tion of HNPCC in CRC would range from 1% (20% of 5%) to
2.5% in the Swedish population aged 0–61 years. As most
HNPCC cases occur before age 62, but only 1/5 of CRCs are diag-
nosed before that age (Centre for Epidemiology, 1999), the etio-
logical proportion of HNPCC in the total population would be
substantially lower than predicted above. 
ACKNOWLEDGEMENTS 
Supported by the King Gustaf V Jubilee fund and The Cancer
Fund. 
REFERENCES 
Aaltonen L, Salovaara R, Kristo P, Canzzian F, Hemminki A, Peltomäki P,
Chadwick R, Kääriäinen H, Eskelinen M, Järvinen H, Mecklin J-P and
Chapelle De La A (1998) Incidence of hereditary nonpolyposis colorectal
cancer and the feasibility of molecular screening for the disease. N Engl J Med
338: 14811–14817 
Aarnio M, Sankila R, Pukkala E, Salovaara R, Aaltonen L, De La Chapelle A,
Peltomäki P, Mecklin J-P and Järvinen H (1999) Cancer risk in mutation
carriers of DNA-mismatch-repair genes. Int J Cancer 81: 214–218 
Boland C (1998) Hereditary nonpolyposis colorectal cancer. In: Vogelstein B and
Kinzler K (eds) The Genetic Basis of Human Cancer pp. 333–346. McGraw-
Hill: New York 
Carstensen B, Soll-Johanning H, Villadsen E, Söndergaard J and Lynge E (1996)
Familial aggregation of colorectal cancer in the general population. Int J
Cancer 68: 428–435 
Centre for Epidemiology (1999) Cancer Incidence in Sweden 1997 pp. 1–114:
Stockholm 
Dong, C and Hemminki K (2001) Modification of cancer risks in offspring by
sibling and parental cancers from 2,112,616 nuclear families. Int J Cancer,
in press 
Esteve J, Benhamou E and Raymond L (1994) Statistical Methods in Cancer
Research Vol. 128. IARC Scientific Publication. IARC: Lyon 
Evans D, Walsh S, Jeacock J, Robinson C, Hadfield L, Davies D and Kingston R
(1997) Incidence of hereditary non-polyposis colorectal cancer in a population-
based study of 1137 consecutive cases of colorectal cancer. Br J Surg 84:
1281–1285 
Fuchs C, Giovannucci E, Colditz G, Hunter D, Speizer F and Willett W (1994)
A prospective study of family history and the risk of colorectal cancer. N Engl
J Med 331: 1669–1674 
British Journal of Cancer (2001) 84(7), 969–974 © 2001 Cancer Research Campaign
972 K Hemminki and X Li Colorectal cancer 973
British Journal of Cancer (2001) 84(7), 969–974 © 2001 Cancer Research Campaign
T
a
b
l
e
 
4
S
I
R
 
f
o
r
 
o
f
f
s
p
r
i
n
g
 
c
o
l
o
r
e
c
t
a
l
 
a
d
e
n
o
c
a
r
c
i
n
o
m
a
 
s
u
b
s
i
t
e
s
 
b
y
 
p
a
r
e
n
t
a
l
 
c
a
n
c
e
r
 
P
a
r
e
n
t
’
s
 
c
a
n
c
e
r
P
r
o
x
i
m
a
l
D
i
s
t
a
l
A
l
l
 
a
g
e
s
<
4
0
A
l
l
 
a
g
e
s
<
4
0
O
S
I
R
9
5
%
 
C
I
O
S
I
R
9
5
%
 
C
I
O
S
I
R
9
5
%
 
C
I
O
S
I
R
9
5
%
 
C
I
 
N
o
 
c
a
n
c
e
r
5
5
9
0
.
8
5
0
.
7
8
0
.
9
2
1
8
5
0
.
8
5
0
.
7
3
0
.
9
8
1
2
6
3
0
.
9
3
0
.
8
8
0
.
9
8
2
7
3
0
.
9
1
0
.
8
1
1
.
0
2
 
U
p
p
e
r
 
a
e
r
o
d
i
g
e
s
t
i
v
e
 
t
r
a
c
t
1
3
1
.
1
9
0
.
6
3
1
.
9
3
3
1
.
0
2
0
.
1
9
2
.
5
1
1
5
0
.
6
4
0
.
3
6
1
.
0
1
1
0
.
2
4
0
.
0
0
0
.
9
5
 
S
a
l
i
v
a
r
y
 
g
l
a
n
d
s
2
1
.
7
7
0
.
1
7
5
.
0
7
3
1
.
2
4
0
.
2
3
3
.
0
4
2
4
.
6
0
0
.
4
3
1
3
.
1
8
 
O
e
s
o
p
h
a
g
u
s
6
1
.
5
8
0
.
5
7
3
.
1
0
1
1
.
0
4
0
.
0
0
4
.
0
9
7
0
.
8
5
0
.
3
4
1
.
6
0
1
0
.
7
4
0
.
0
0
2
.
9
0
 
S
t
o
m
a
c
h
3
7
1
.
4
1
0
.
9
9
1
.
9
0
1
2
1
.
9
9
1
.
0
2
3
.
2
8
5
1
0
.
8
8
0
.
6
6
1
.
1
4
9
1
.
0
6
0
.
4
8
1
.
8
6
 
S
m
a
l
l
 
i
n
t
e
s
t
i
n
e
6
3
.
0
1
1
.
0
8
5
.
9
0
2
3
.
7
0
0
.
3
5
1
0
.
6
0
5
1
.
1
7
0
.
3
7
2
.
4
3
1
1
.
3
2
0
.
0
0
5
.
1
6
 
C
o
l
o
r
e
c
t
u
m
1
1
2
2
.
0
3
1
.
6
7
2
.
4
3
3
4
2
.
4
4
1
.
6
9
3
.
3
3
2
3
3
1
.
9
5
1
.
7
1
2
.
2
1
4
3
2
.
1
9
1
.
5
8
2
.
8
9
 
A
d
e
n
o
c
a
r
c
i
n
o
m
a
1
0
6
2
.
0
6
1
.
6
8
2
.
4
7
3
3
2
.
5
2
1
.
7
3
3
.
4
5
2
2
4
2
.
0
1
1
.
7
6
2
.
2
8
4
1
2
.
2
0
1
.
5
8
2
.
9
3
 
P
r
o
x
i
m
a
l
3
6
2
.
3
2
1
.
6
2
3
.
1
3
9
2
.
3
1
1
.
0
5
4
.
0
7
6
3
1
.
8
7
1
.
4
4
2
.
3
6
1
1
2
.
0
0
0
.
9
9
3
.
3
6
 
D
i
s
t
a
l
6
1
1
.
9
3
1
.
4
7
2
.
4
4
2
1
2
.
5
9
1
.
6
0
3
.
8
2
1
3
7
2
.
0
0
1
.
6
8
2
.
3
5
2
4
2
.
1
0
1
.
3
4
3
.
0
3
 
L
i
v
e
r
1
6
1
.
0
2
0
.
5
8
1
.
5
8
7
1
.
8
4
0
.
7
3
3
.
4
5
3
1
0
.
9
1
0
.
6
2
1
.
2
6
6
1
.
1
1
0
.
4
0
2
.
1
8
 
P
a
n
c
r
e
a
s
1
7
1
.
0
9
0
.
6
3
1
.
6
6
3
0
.
7
8
0
.
1
5
1
.
9
1
3
2
0
.
9
4
0
.
6
4
1
.
2
9
4
0
.
7
4
0
.
1
9
1
.
6
3
 
L
u
n
g
3
3
1
.
0
1
0
.
6
9
1
.
3
8
9
1
.
0
0
0
.
4
5
1
.
7
6
6
4
0
.
9
2
0
.
7
1
1
.
1
6
1
0
0
.
7
9
0
.
3
8
1
.
3
5
 
B
r
e
a
s
t
5
4
1
.
0
8
0
.
8
1
1
.
3
9
9
0
.
6
2
0
.
2
8
1
.
1
0
1
1
6
1
.
1
0
0
.
9
1
1
.
3
1
2
3
1
.
1
4
0
.
7
2
1
.
6
5
 
C
e
r
v
i
x
1
2
1
.
0
7
0
.
5
5
1
.
7
6
3
0
.
9
2
0
.
1
7
2
.
2
5
2
2
0
.
9
3
0
.
5
8
1
.
3
6
6
1
.
3
1
0
.
4
7
2
.
5
6
 
E
n
d
o
m
e
t
r
i
u
m
3
2
2
.
3
2
1
.
5
9
3
.
2
0
1
2
3
.
1
4
1
.
6
1
5
.
1
6
4
5
1
.
5
4
1
.
1
2
2
.
0
2
1
2
2
.
2
3
1
.
1
5
3
.
6
7
 
O
v
a
r
y
1
7
1
.
4
2
0
.
8
2
2
.
1
7
6
1
.
8
1
0
.
6
5
3
.
5
5
2
8
1
.
0
9
0
.
7
3
1
.
5
4
7
1
.
5
0
0
.
6
0
2
.
8
2
 
O
t
h
e
r
 
f
e
m
a
l
e
 
g
e
n
i
t
a
l
s
1
0
.
4
6
0
.
0
0
1
.
8
0
7
1
.
4
6
0
.
5
8
2
.
7
5
P
r
o
s
t
a
t
e
7
9
1
.
2
6
1
.
0
0
1
.
5
5
2
0
1
.
2
7
0
.
7
7
1
.
8
8
1
2
3
0
.
9
1
0
.
7
5
1
.
0
7
2
0
0
.
9
0
0
.
5
5
1
.
3
3
 
K
i
d
n
e
y
2
1
1
.
2
9
0
.
8
0
1
.
9
0
1
0
.
2
3
0
.
0
0
0
.
9
1
3
8
1
.
0
8
0
.
7
7
1
.
4
6
6
0
.
9
9
0
.
3
5
1
.
9
3
 
U
r
i
n
a
r
y
 
b
l
a
d
d
e
r
2
9
1
.
3
5
0
.
9
0
1
.
8
8
6
1
.
0
5
0
.
3
8
2
.
0
6
5
6
1
.
2
1
0
.
9
1
1
.
5
5
7
0
.
8
7
0
.
3
4
1
.
6
3
 
M
e
l
a
n
o
m
a
7
0
.
7
7
0
.
3
1
1
.
4
5
2
0
.
6
6
0
.
0
6
1
.
8
9
2
5
1
.
3
4
0
.
8
7
1
.
9
2
8
1
.
9
0
0
.
8
1
3
.
4
4
 
S
k
i
n
1
2
0
.
8
0
0
.
4
1
1
.
3
2
6
1
.
6
8
0
.
6
1
3
.
3
0
2
6
0
.
8
0
0
.
5
2
1
.
1
3
4
0
.
7
9
0
.
2
1
1
.
7
6
 
E
y
e
3
1
.
0
8
0
.
2
0
2
.
6
4
2
3
.
9
2
0
.
3
7
1
1
.
2
3
 
N
e
r
v
o
u
s
 
s
y
s
t
e
m
1
6
1
.
2
7
0
.
7
2
1
.
9
6
5
1
.
3
2
0
.
4
2
2
.
7
4
3
5
1
.
3
2
0
.
9
2
1
.
7
9
1
3
2
.
4
6
1
.
3
0
3
.
9
7
 
T
h
y
r
o
i
d
 
g
l
a
n
d
4
1
.
1
4
0
.
3
0
2
.
5
3
6
0
.
8
1
0
.
2
9
1
.
5
9
1
0
.
6
9
0
.
0
0
2
.
7
2
 
E
n
d
o
c
r
i
n
e
 
g
l
a
n
d
s
8
1
.
0
6
0
.
4
5
1
.
9
1
3
1
.
3
2
0
.
2
5
3
.
2
4
1
6
1
.
0
1
0
.
5
7
1
.
5
6
B
o
n
e
4
5
.
8
7
1
.
5
3
1
3
.
0
3
4
2
.
7
8
0
.
7
2
6
.
1
7
1
3
.
6
0
0
.
0
0
1
4
.
1
0
 
C
o
n
n
e
c
t
i
v
e
 
t
i
s
s
u
e
4
1
.
3
8
0
.
3
6
3
.
0
6
2
2
.
5
0
0
.
2
4
7
.
1
7
1
0
1
.
6
2
0
.
7
7
2
.
7
7
2
1
.
7
8
0
.
1
7
5
.
1
1
 
L
y
m
p
h
o
m
a
1
1
0
.
7
6
0
.
3
8
1
.
2
8
3
0
.
7
5
0
.
1
4
1
.
8
4
2
6
0
.
8
4
0
.
5
5
1
.
2
0
3
0
.
5
3
0
.
1
0
1
.
3
1
 
M
y
e
l
o
m
a
1
0
1
.
3
4
0
.
6
4
2
.
3
0
3
1
.
6
1
0
.
3
0
3
.
9
4
1
7
1
.
0
5
0
.
6
1
1
.
6
1
4
1
.
5
2
0
.
3
9
3
.
3
7
 
L
e
u
k
a
e
m
i
a
1
0
0
.
7
7
0
.
3
7
1
.
3
2
3
0
.
9
0
0
.
1
7
2
.
2
1
2
9
1
.
0
4
0
.
6
9
1
.
4
5
7
1
.
4
9
0
.
5
9
2
.
8
1
 
A
n
y
 
c
a
n
c
e
r
5
7
6
1
.
3
0
1
.
2
0
1
.
4
1
1
5
6
1
.
3
3
1
.
1
3
1
.
5
4
1
0
7
8
1
.
1
3
1
.
0
7
1
.
2
0
2
0
4
1
.
2
3
1
.
0
7
1
.
4
1
 
B
o
l
d
 
t
y
p
e
:
 
9
5
%
 
C
I
 
d
o
e
s
 
n
o
t
 
i
n
c
l
u
d
e
 
1
.
0
0
.
 Hemminki K and Li X (2001) Increased cancer risk in offspring of women
with colorectal carcinoma. A Swedish register-based cohort study. Cancer, 91:
1061–1063
Hemminki K and Vaittinen P (1999) Familial cancers in a nation-wide family-cancer
database: age distribution and prevalence. Eur J Cancer 35: 1109–1111 
Hemminki K, Vaittinen P and Kyyrönen P (1998) Age-specific familial risks in
common cancers of the offspring. Int J Cancer 78: 172–175 
Hemminki K, Vaittinen P and Dong C (1999) Endometrial cancer in the Family-
Cancer Database. Cancer Epidemiol Biomarkers Prev 8: 1005–1010 
Hemminki K, Vaittinen P, Dong C and Easton D (2001) Sibling risks in cancer: clues
to recessive or X-linked genes? Br J Cancer 84: 388–391
IARC (1990) Cancer: causes, occurence and control Vol. 100. IARC Scientific
Publications. IARC: Lyon 
Lichtenstein P, Holm N, Verkasalo P, Illiado A, Kaprio J, Koskenvuo M, Pukkala E,
Skytthe A and Hemminki K (2000) Environmental and heritable factors in the
causation of cancer. N Engl J Med 343: 78–85 
Lynch H and de la Chapelle A (1999) Genetic susceptibility to non-polyposis
colorectal cancer. J Med Genet 36: 801–818 
Lynch H and Smyrk T (1996) Hereditary nonpolyposis colorectal cancer (Lynch
syndrome). Cancer 78: 1149–1167 
Peel D, Ziogas A, Fox E, Gildea M, Laham B, Clements E, Kolodner R and 
Anton-Culver H (2000) Characterization of hereditary nonpolyposis colorectal
cancer families from a population-based series of cases. J Natl Cancer 1st 92:
1517–1522 
Potter J (1999) Colorectal cancer: molecules and populations. J Natl Cancer Inst 91:
916–932 
Rothman K and Greenland S (1998) Modern Epidemiology Lippincott-Raven:
Philadelphia 
Salovaara R, Loukola A, Kristo P, Kaariainen H, Ahtola H, Eskelinen M, Harkonen
N, Julkunen R, Kangas E, Ojala S, Tulikoura J, Valkamo E, Jarvinen H,
Mecklin J, Aaltonen L and de la Chapelle A (2000) Population-based
molecular detection of hereditary nonpolyposis colorectal cancer. J Clin Oncol
18: 2193–2200 
Vasen H, Mecklin J-P, Meera Khan P and Lynch H (1991) The international
collaborative group on hereditary non-polyposis colorectal cancer 
(ICG-HNPCC). Diseases Colon Rectum 34: 424–425 
Vogelstein B and Kinzler KW (1998) The genetic basis of human cancer. McGraw-
Hill: New York 
Wheeler J, Bodmer W and Mortensen N (2000) DNA mismatch repair genes and
colorectal cancer. Gut 47: 148–153 
974 K Hemminki and X Li 
British Journal of Cancer (2001) 84(7), 969–974 © 2001 Cancer Research Campaign